|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.150 HKD | +0.98% |
|
+12.69% | -34.39% |
| 06-05 | Grand Pharmaceutical Group Limited Declares Final Dividend for the Year Ended 31 December 2025 | CI |
| 04-13 | Grand Pharmaceutical Says Liver Cancer Treatment Reaches Clinical Endpoint | MT |
| Market Cap | 18.03B 2.3B 2.01B 1.85B 1.72B 3.27B 219B 3.32B 22.18B 8.62B 108B 8.63B 8.45B 371B | P/E 2026 * |
9.54x | P/E 2027 * | 8.78x |
|---|---|---|---|---|---|
| Enterprise Value | 18.03B 2.3B 2.01B 1.85B 1.72B 3.27B 219B 3.32B 22.18B 8.62B 108B 8.63B 8.45B 371B | EV / Sales 2026 * |
1.34x | EV / Sales 2027 * | 1.22x |
| Free-Float |
23.76% | Yield 2026 * |
4.66% | Yield 2027 * | 5.44% |
| 1 day | +0.98% | ||
| 1 week | +12.69% | ||
| Current month | +9.57% | ||
| 1 month | -0.77% | ||
| 3 months | -28.67% | ||
| 6 months | -33.97% | ||
| Current year | -34.39% |
| 1 week | 4.54 |  | 5.29 |
| 1 month | 4.53 | | 5.29 |
| Current year | 4.53 | | 8.18 |
| 1 year | 4.53 | | 9.89 |
| 3 years | 3.17 | | 10.2 |
| 5 years | 3.17 | | 10.2 |
| 10 years | 1.35 | | 10.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 36 | 2021-05-31 |
Tin Chung Foo
SEC | Corporate Secretary | 57 | 2011-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 63 | 2010-02-24 |
Ye Bi Hu
BRD | Director/Board Member | 62 | 2018-12-30 |
Geng Pei
BRD | Director/Board Member | 66 | 2011-05-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-21 | Other | Chairman | 50,000 | 0.0014% | ||
| 04-20 | Other | Chief Executive Officer | 58,500 | 0.0016% | ||
| 03-26 | Other | Chairman | 60,000 | 0.0017% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | +12.69% | -44.08% | +16.52% | 2.3B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +32.57% | +24.89% | 338B | |
| -0.56% | +0.96% | +41.67% | +39.35% | 299B | |
| -0.08% | +1.30% | +32.15% | +44.48% | 291B | |
| -1.54% | +2.81% | -25.35% | -39.61% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.98% | +5.39% | +24.19% | +54.05% | 369.47B | |
| Weighted average by Cap. | +2.24% | +5.54% | +42.26% | +83.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.47B 1.72B 1.5B 1.38B 1.29B 2.44B 164B 2.48B 16.56B 6.44B 80.38B 6.45B 6.31B 277B | 14.78B 1.88B 1.65B 1.51B 1.41B 2.68B 179B 2.72B 18.18B 7.07B 88.21B 7.07B 6.92B 304B |
| Net income | 1.91B 244M 213M 196M 183M 346M 23.22B 352M 2.35B 914M 11.41B 915M 896M 39.33B | 2.09B 266M 233M 214M 199M 378M 25.32B 383M 2.57B 997M 12.45B 998M 977M 42.89B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | HK$5.150 | +0.98% | 5,682,330 |
| 26-07-02 | HK$5.100 | +8.51% | 11,741,330 |
| 26-06-30 | HK$4.700 | -1.47% | 7,341,500 |
| 26-06-29 | HK$4.770 | +4.38% | 6,819,000 |
| 26-06-26 | HK$4.570 | -1.72% | 6,129,901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 512 Stock
Select your edition
All financial news and data tailored to specific country editions
